CLICK HERE to view the agenda (.PDF)

The landscape of risk assessment is changing. These changes are driven largely by phenomenal advances in molecular and systems biology, recent reports from the National Research Council, and volumes of new test data arising from theTox21 and European REACH programs. These drivers are prompting us to look anew at current efforts to advance risk assessment through systems biology data and ask how it can augment, extend, or replace traditional data. The goal for this meeting is to consider these emerging sciences in systems biology as tools to inform risk assessment and decision making and to identify what key issues must be addressed. We will present the concepts and problems of current approaches to risk assessment and discuss the direction and means of advancing using concrete examples.

Looking Toward the Horizon of Risk Assessment

Advancing Current Risk Assessment with Systems Biology

 - Addressing the screening, response, and application to human populations

Value of Information and Decision-making with Systems Biology Data

How to Apply Concepts to Future of Risk Assessment

Kim Boekelheide, Professor of Medical Sciences at Brown University

Lauren Zeise, Chief of Reproductive and Cancer Hazard Assessment, California EPA

Derek Knight, Senior Scientific Advisor at European Chemicals Agency

Ila Cote, Senior Science Advisor, National Center for Environmental Assessment, EPA

Dean Jones, Professor Medicine at Emory University

Maurice Whelan, Head of Systems Toxicology, European Commission

Robert Devlin, Senior Scientist in the Environmental Public Health Division of EPA

Greg Paoli, Co-founder of Risk Sciences International

More information on this workshop will be available soon. Please check here for updates.